Thank you, Steve. Revenue in first quarter 2016 was $5.1 million down 17% from $6.1 million in the first quarter of 2015. This was principally due to loss of clients during 2015 from CastleRock, Practicare and Omni companies we repurchased at the time of the IPO. Revenue from these three acquisitions was down $1.8 million from first quarter 2015 to first quarter 2016 and was partially offset by revenue from several smaller acquisitions during 2015, as well as Gulf Coast. Additionally the first quarter is seasonally our lowest in terms of revenue and profits, similar to other ambulatory practice management and revenue cycle management providers. Both insurance plans contained an annual deductable, so when the patient visits their doctor during the first quarter, the fee is often part of the patients deductable. Instead of insurance paying the doctor, the doctor has to wait, so the patient has to pay the deductable themselves. We recognized revenue when the doctor is actually paid and thus our fees are determinable so while providers wait for patient payments which generally take longer than insurance payments our revenues are delayed. Since our expenses reflect the work of submitting a constant level of claims, even though payment to our doctors are down, we normally anticipate negative adjusted EBITDA during the first quarter of each year achieving positive adjusted EBITDA this quarter is a result of automating manual processes and moving enough work offshore to allow us to reduce costs and offset this seasonal decline in revenue. The $65,000 adjusted EBITDA in the first quarter of 2016 is a significant improvement from the negative $710,000 adjusted EBITDA in the first quarter of last year. We reduced direct operating cost by 35% from $3.5 million to $2.3 million and reduced general and administrative expenses from $3.1 million to $2.9 million. We expect to continue to reduce expenses from Gulf Coast and Renaissance and to continue to report positive adjusted EBITDA during the fiscal year ended December 31, 2016. The difference of $2 million between adjusted EBITDA and the GAAP loss in the first quarter of 2016 reflects $1.2 million of non-cash amortization and depreciation expense, $489,000 of stock based compensation, $212,000 of integration and transaction costs related to the recent acquisitions, $43,000 of provision for taxes, and $134,000 of net interest expense. This was offset by a $45,000 decrease in the contingent consideration liability. There was also a significant improvement in our non-GAAP adjusted net income from negative $854,000 or negative $0.08 per share during first quarter 2015 to negative $217,000 or negative $0.02 per share during first quarter 2016. On a GAAP basis, in the first quarter of 2016 we had a $2 million loss or $0.21 per share. While this is greater than the $1.2 million loss in the first quarter of 2015, the first quarter of 2015 was helped by an $829,000 non-cash reduction in the value of the shares held in Escrow for the sellers in the three companies we acquired at the time of the IPO, while the first quarter of 2016 included a similar benefit of only $45,000. Our $2 million GAAP loss also includes $1.2 million of non-cash amortization and depreciation and $489,000 of stock based compensation expense. As of March 31, MTBC's cash balance was approximately $7.4 million compared to approximately $8 million as of December 31, 2015. During December of 2016, MTBC's Board of Directors authorized a common stock repurchase program allowing the company to return value to existing shareholders by purchasing MTBC shares at prices that we believe to be very attractive. We purchased approximately 100,000 shares under this one month program. During January of 2016 with global equity markets in turmoil, our Board authorized a $1 million stock repurchase program which will run through January of 2017. As our share price has remained at levels that we believe to be undervalued, we have purchased approximately 646,000 additional shares under this program so far. In total, we spent approximately $668,000 repurchasing shares. All shares are repurchased in open market transactions in accordance with all applicable securities laws and regulations including Rule 10b-18 of the Securities Exchange Act of 1934 as amended. In March we filed an S-3 shelf registration statement with the SEC which is now effective. We believe we have plenty of cash for operating expenses but having an effective shelf registration statement may provide us with additional flexibility in the future. The significant acquisition opportunity arises which requires more capital that we have available, the shelf registration statement might allow us to reopen our non-convertible Series A preferred stock and raise funds in the public market more quickly and easily in filing an S-1 registration statement. Finally, we are reaffirming our 2016 full year revenue guidance of $27 million to $30 million which represents growth of $4 million to $7 million over 2015 revenue. This includes revenue from the recent acquisitions of Gulf Coast Billing and Renaissance Physician Services. We believe revenue will rise cyclically during second quarter 2016 after the largest impact of deductibles will likely be behind us and we recognize a full quarter of revenue from Gulf Coast billing and a partial quarter from Renaissance. We're also reaffirming our 2016 full year adjusted EBITDA guidance of $1.5 million to $2 million and reaffirming our non-GAAP adjusted net income per share guidance of between negative $0.05 and negative $0.10 per share. That concludes my review of MTBC's first quarter financial results. And I'll now turn the call over to our Chairman and CEO, Mahmud Haq for some closing remarks. Mahmud?